Exploring Masking Technology to Enhance Specificity & Cytotoxic Activity of Bispecifics
- Overview of the masking technology and engineering approaches for enhanced tissue specificity of bispecifics
- Choice of optimal substrate specificity for tumor-associated protease-mediated prodrug activation
- In vitro safety assessments for reduced systemic toxicity for the design of nextgeneration cancer therapeutics